2 years | 180 days | 2 years | |||||||
---|---|---|---|---|---|---|---|---|---|
Relapse | NRM | LFS | OS | GRFS | Acute GVHD II-IV | Acute GVHD III-IV | Chronic GVHD | Ext. chronic GVHD | |
FD | 22.6% [17.8–27.7] | 17.7% [13.5–22.3] | 59.7% [53.7–65.3] | 68.3% [62.5–73.5] | 47.8% [41.8–53.6] | 29.1% [24–34.4] | 9.1% [6.2–12.7] | 31% [25.6–36.6] | 9.9% [6.6–13.9] |
NFD | 21.1% [13.9–29.3] | 13.2% [7.7–20.2] | 65.7% [55.9–73.9] | 71.8% [62.3–79.4] | 50.9% [41–60] | 24% [16.8–31.9] | 10.7% [6–17] | 38.9% [29.4–48.3] | 15.3% [9.1–22.9] |
HR (95% CI) | 1.04 (0.69–1.58) | 0.77 (0.45–1.31) | 0.92 (0.66–1.27) | 0.9 (0.63–1.28) | 0.95 (0.72–1.25) | 0.8 (0.52–1.23) | 1.28 (0.68–2.4) | 1.17 (0.81–1.69) | 1.44 (0.82–2.52) |
p value | 0.84 | 0.33 | 0.6 | 0.56 | 0.69 | 0.31 | 0.44 | 0.41 | 0.2 |